Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Home > IPO Details

DR. AGARWAL’S HEALTH CARE LIMITED

29 Jan 2025 - 31 Jan 2025 Employee Category Main Board BSE NSE
Apply Now

Min Investment

₹14070

Price Band

₹382-₹402

Issue Size

535.26 lakhs
Equity Shares

Lot Size

35

IPO Dates
img

29 Jan 2025

Open Date

img

31 Jan 2025

Close Date

img

03 Feb 2025

Allotment Date

img

05 Feb 2025

Listing Date

Dr. Agarwal's Healthcare IPO open date is 29 January to 31 January, 2025. This new IPO is a book-built issue of up to 5.35 lakh equity shares. This upcoming IPO is a combination of fresh issue and offer-for-sale. The fresh issue is worth up to of Rs 300 crore and offer-for-sale is worth up to Rs 2,727.26 crore.Dr. Agarwal's Healthcare IPO price band is Rs 382 – Rs 402 per share. As of now, Dr. Agarwal's Healthcare IPO GMP Live quotation is at Rs 164 per share.  Live IPO Grey Market Premium details is visible online.Dr. Agarwal's Healthcare IPO allotment status will be finalised on 3 February 2025. The lot size is 35 shares. The minimum investment for the retail investors for 1 lot is Rs 14,070. The registrar for Dr. Agarwal's Healthcare IPO is Kfin Technologies Limited.

Know Before Investing

Strengths icon

  • Largest eye care provider with 193 facilities nationwide.
  • Strong expertise with 737 doctors serving 2.13M patients.
  • Efficient hub-and-spoke model across 117 cities in India.

Weaknesses icon

  • High dependence on skilled medical professionals for growth.
  • Declining return on net worth and debt coverage ratio.
  • Operating profitability pressured by aggressive expansion investments.

About Dr. Agarwal’s Health Care Limited

Dr. Agarwal’s Healthcare Limited established in 1957, is a leading provider of eyecare services in India and Africa. It is known for its advanced treatment and innovative practices.The company operates over 180 facilities, including 165 in India and 15 in the African countries. Dr. Agarwal is specialized in cataract surgeries, refractive procedures, retinal care, corneal transplant and other ophthalmic treatments. They have treated over 2.13 million patients and performed 2,20,000 surgeries in 2024. The company is backed by global investors, TPG Growth and Temasek. They have been expanding its network to 300 centers and positioned themselves as key players in organised eye care services.

Founded

1957

Managing Director

Dr. Amar Agarwal

Parent Organization

IPO Objectives

The funds raised from the Dr. Agarwal's Healthcare IPO will be used for expanding the eyecare business. Also, the remaining money will be used for the capital expenditure and meeting the working capital needs. Other than this, the money will be used for meeting the working capital purposes.

Company Promoters

Dr. Amar Agarwal

Dr. Athiya Agarwal

Dr Adil Agarwal

Dr. Anosh Agarwal

Dr Ashvin Agarwal

Dr. Ashar Agarwal

Dr. Amar Agarwal Family Trust

Dr Adil Agarwal Family Trust

Dr. Anosh Agarwal Family Trust

Dr Ashvin Agarwal Family Trust

Dr. Ashar Agarwal Family Trust

Dr Agarwal’s Eye Institute

Dr Agarwal's Eye Institute Private Limited

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 0
Non-Institutional Buyers 0
bNII (bids above ₹10L) 0
sNII (bids below ₹10L) 0
Retail Investors 0
Employees 0
Others 0
Total 0
img
Apply Now

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account